Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validity Reliability of The Dubousset Functional Test in Parkinson Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04622657
Recruitment Status : Recruiting
First Posted : November 10, 2020
Last Update Posted : November 13, 2020
Sponsor:
Information provided by (Responsible Party):
Ayşe Abit Kocaman, Kırıkkale University

Brief Summary:

In order to achieve collaborative patient-centered rehabilitation in Parkinson's disease, detailed evaluation of walking and balance in evaluating the perceived difficulty in daily life is important to evaluate the progression of the disease and its response to treatments.

In the literature, there are many scales that evaluate balance and functional performance in Parkinson Disease. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of Parkinson Disease. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in Parkinson Disease.


Condition or disease Intervention/treatment Phase
Parkinson Disease Balance; Distorted Fall Gait Disorders, Neurologic Other: dubousset functional test Not Applicable

Detailed Description:

Balance disorders are very common in patients with Parkinson's, and these disorders significantly affect the patient's body alignment and participation. Especially during walking, balance disorders occur, resulting in falls, disability and injury in the advanced stage of the disease. As a result of these losses in patients, falls can be seen, and the severity of disability that increases with age affects the quality of life of individuals by affecting their living in their own homes.

Dubousset Functional Test (DFT); A conceptually practical four-component assessment test has been proposed by Dr. Jean Dubousset to assess the functional capacity of adult individuals. The validity of the test was made in individuals with spinal deformity. DFT; It consists of four components: getting up from a chair without arms and walking 5 meters forward and backward, descending and climbing steps, transition from standing to sitting on the ground, and the dual task test in which the individual walks while counting down from 50 at the same time

In the literature, there are many scales that evaluate balance and functional performance in Parkinson Disease. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of Parkinson Disease. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in Parkinson Disease.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Intervention Model: Sequential Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Validity Reliability of The Dubousset Functional Test in Parkinson Disease
Actual Study Start Date : October 25, 2020
Estimated Primary Completion Date : April 1, 2021
Estimated Study Completion Date : April 15, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: parkinson disease
Assessment
Other: dubousset functional test
Dubousset Function Test, 3-m backwards walk test, timed up and go test,Tinnetti Balance and Gait Test, Berg BalanceTest, Functional Reach Test




Primary Outcome Measures :
  1. Dubousset Function Test [ Time Frame: through study completion, an average of 1 year ]
    The four components of the DFT included (1) the Up Walking Test: participants rose without assistance from a and seated position in a chair that did not have arms, walked 5 meters (500 cm) forward before stopping, walked backwards 5 meters, and sat again without assistance; (2) the Steps Test: from a starting position 50 cm away, volunteers climbed three stairs, turned around on the third step (top), and walked down the three steps; (3) Down and Sitting Test: from a standing position, participants sat on the ground and stood up again, using assistance as needed; (4) Dual-Tasking Test: participants walked 5 meters forward, turned around, and walked 5 meters back to the starting position while performing a working memory test (counting down from 50 by intervals of 2).

  2. timed up and go test [ Time Frame: through study completion, an average of 1 year ]
    A standard chair is used for testing. First, the patient is asked to sit on the chair. The patient is then asked to stand up and walk regularly at a distance of 3 meters with a predetermined length, then return to the chair after 3 meters.

  3. 3-m backwards walk test [ Time Frame: through study completion, an average of 1 year ]

    A distance of 3 m is measured and marked with black tape. Individuals are asked to follow the heel and black band.

    With the 'start' command they are asked to walk backwards quickly. When the distance of 3 m is completed, a stop is instructed. Individuals are not allowed to run during the test. They are allowed to look back if they wish. The assessor walks behind individuals throughout the test. The test is repeated 3 times, the averages are recorded


  4. Tinetti Balance and Gait Test [ Time Frame: through study completion, an average of 1 year ]
    In the test used to evaluate balance, walking score is maximum 12 points, balance score is maximum 16 points and a total of 28 points.

  5. Funtional Reach Test [ Time Frame: through study completion, an average of 1 year ]
    It is used to measure both the balance of the individual functionally and the amount of dynamic reach It is used to measure both the balance of the individual functionally and the amount of dynamic reach

  6. Berg Balance Test [ Time Frame: through study completion, an average of 1 year ]
    The BBS consists of 14 items to directly monitor the maintenance of body balance during performance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Being diagnosed with Parkinson's Disease (Hoehn Yahr level (1-3)

  • Volunteering to participate in research and approving the informed consent form Being over the age of 40
  • Using stable Parkinson's Disease medication for at least 4 weeks
  • No cooperation and communication problems

Exclusion Criteria:

  • • Individuals with any other neurological and orthopedic problems Uncontrollable hypertension To your serious disk Significant comorbidity affecting balance and gait

    • Those with cooperation and communication problems

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04622657


Contacts
Layout table for location contacts
Contact: Ayşe Abit Kocaman, PhD +90318-357 37 38 / 7500 ayseabit@gmail.com
Contact: Ayşe Abit Kocaman, PhD

Locations
Layout table for location information
Turkey
Ayşe Abit Kocaman Recruiting
Kırıkkale, Turkey, 7110
Contact: Ayşe A Kocaman, Phd         
Sponsors and Collaborators
Kırıkkale University
Investigators
Layout table for investigator information
Principal Investigator: Ayşe Abit Kocaman, PhD Kırıkkale University
Publications:
Layout table for additonal information
Responsible Party: Ayşe Abit Kocaman, Principal Investigator, Kırıkkale University
ClinicalTrials.gov Identifier: NCT04622657    
Other Study ID Numbers: Parkinson Disease Assesment
First Posted: November 10, 2020    Key Record Dates
Last Update Posted: November 13, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Nervous System Diseases
Gait Disorders, Neurologic
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Neurologic Manifestations